Early Intervention Strategies for Patients With T2D & ASCVD Risk

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Early Intervention Strategies for Patients With T2D & ASCVD Risk



ReachMD Healthcare Image

Explore evidence-based recommendations to care for type 2 diabetes mellitus patients with established ASCVD risk in two interactive, hypothetical patient cases.

  • Sponsored by

  • Overview

    For patients with type 2 diabetes (T2D) and a history of cardiovascular disease, the ADA and AACE recommend an A1c goal of less than or equal to 7 percent or as close to normal as possible.1,2 Along with appropriate management of blood pressure, lipids, and weight, patients may be able to reduce their cardiovascular risk.1 How would you approach caring for patients with T2D and cardiovascular risk? Walk through this virtual simulation to develop individualized, evidenced-based care plans for two hypothetical patients.

    Standards of Care in Diabetes—2023. Clin Diabetes. 2023;41(Supplement 1).
    2. Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update. Endocr Pract. 2023;29(5):305-340. Doi:10.1016/J.EPRAC.2023.02.001

    Novo Nordisk is a registered trademark of Novo Nordisk A/S.
    © 2023 Novo Nordisk All rights reserved.
    US23DI00175 August 2023

Schedule22 May 2024